Skip to content

The effect of natural sweetener lacrithosis on blood glucose in type 2 diabetic patients

Comparison of average blood sugar in people with type II diabetes natural sweetener consumers Lacriroze and control group-clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017102418858N7
Enrollment
30
Registered
2017-11-13
Start date
2017-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-insulin-dependent diabetes mellitus.

Interventions

Intervention 1: Sucrose and Lacritoze. Intervention 2: Lacritoze. Intervention 3: Sucrose.
Lifestyle
Placebo
Sucrose and Lacritoze
Lacritoze
Sucrose

Sponsors

University of Medical Sciences and Health Services, Yazd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Type 2 diabetes, the age group of 30-60, fasting blood glucose less than 200 mg / dl, HbA1C=9=7, are under the control of oral hypoglycemic or dietary medications, are not treated with insulin. Sugar in the diet of the patient. Drugs for blood sugar, blood lipids and blood pressure did not change during the past month, having a medical record at the Yazd diabetes research center, a willingness to participate in research. Exclusion criteria: Patient's inability to follow-up (life in the city, end stage, patients who need to control high blood sugar due to complications of diabetes, those who have a severe change in their calories and their activity, people with deficiency of Lactose, pregnancy And lactation, patients with severe infections or endocrine disorders, those with acute illnesses, people with liver and kidney failure, patients with diabetes complications (nephropathy, neuropathy, retinopathy), BMI=35

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
FBS. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;2hPP. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;Fructosamine. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;Insulin. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;Urea. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;Cr. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;SGOT. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.;SGPT. Timepoint: Before the intervention, After the intervention. Method of measurement: Blood Test.

Secondary

MeasureTime frame
BMI. Timepoint: Before the intervention, After the intervention. Method of measurement: Balance and meter.;Digestive complications. Timepoint: Before the intervention, After the intervention. Method of measurement: Questionare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhghan Modarresi

Yazd University of Medical Science

mdmodarresi@gmail.com+98 35 3728 0226

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026